Discovery of Hexahydrofuro[3,2‑b]furans as New Kinase-Selective and Orally Bioavailable JAK3 Inhibitors for the Treatment of Leukemia Harboring a JAK3 Activating Mutant
Article in Journal of Medicinal Chemistry (July 2022)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Journal of Medicinal Chemistry (July 2022)